Researchers at Avila Therapeutics have developed the first-ever covalent irreversible inhibitors of a viral protease, achieving high selectivity and potency. The newly designed compounds irreversibly bind to molecular domains specific to proteases, offering a promising therapeutic approach for hepatitis C infection.
Researchers at Delft University of Technology and Oxford University have developed a new, more robust type of nanopore device that combines biological and artificial building blocks. This technology has the potential to revolutionize DNA analysis by making it faster and cheaper.
A University of Gothenburg study finds that China's plastic bag charging policy reduces consumption by half, with 60% still not complying. The ordinance allows store owners to price bags and keep profits, but competition remains fierce.
Researchers at the University of Gothenburg have discovered that superantigens, produced by staphylococcus bacteria, can activate the immune system in more ways than previously thought. This complex interaction may be behind several illnesses, including long-term wound infections and autoimmune disorders.
The European Science Foundation's TECHBREAK initiative aims to identify key enabling technologies that can benefit the space sector. By combining expertise from both space and non-space sectors, TECHBREAK seeks to accelerate scientific progress and innovation.
A recent study reveals that Amazonia's incredible biodiversity originated from the formation of the Andes mountains, dating back over 65 million years. The study found a strong correlation between the mountain's creation and the development of Amazonian species.
Researchers at King's College London have discovered a new gene associated with Hypospadias, a congenital malformation of the male genitalia. The study found that changes in the DGKK gene are strongly linked to an increased risk of hypospadias.
Researchers at the University of Leeds have successfully created artificial spin ice, a state-of-the-art nanomaterial that has been difficult to produce in the past. By achieving thermal equilibrium, they can now study the precise configuration of magnetic monopoles and their potential applications in magnetricity.
Scientists discovered that increasing EphB2 levels can fix memory problems caused by amyloid proteins in a mouse model of Alzheimer's disease. The study found that blocking amyloid proteins from binding to EphB2 and enhancing its functions may be beneficial for AD treatment.